Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iovance Biotherapeutics (IOVA) Exchange Rate Effect (2023 - 2025)

Iovance Biotherapeutics has reported Exchange Rate Effect over the past 3 years, most recently at $577000.0 for Q4 2025.

  • Quarterly results put Exchange Rate Effect at $577000.0 for Q4 2025, up 148.98% from a year ago — trailing twelve months through Dec 2025 was $1.1 million (up 311.46% YoY), and the annual figure for FY2025 was $1.1 million, up 311.46%.
  • Exchange Rate Effect for Q4 2025 was $577000.0 at Iovance Biotherapeutics, up from -$680000.0 in the prior quarter.
  • Over the last five years, Exchange Rate Effect for IOVA hit a ceiling of $3.0 million in Q4 2023 and a floor of -$3.8 million in Q2 2023.
  • Median Exchange Rate Effect over the past 3 years was -$125000.0 (2024), compared with a mean of -$194272.7.
  • Peak annual rise in Exchange Rate Effect hit 691.2% in 2025, while the deepest fall reached 154.27% in 2025.
  • Iovance Biotherapeutics' Exchange Rate Effect stood at $3.0 million in 2023, then tumbled by 138.99% to -$1.2 million in 2024, then surged by 148.98% to $577000.0 in 2025.
  • The last three reported values for Exchange Rate Effect were $577000.0 (Q4 2025), -$680000.0 (Q3 2025), and $739000.0 (Q2 2025) per Business Quant data.